1. Home
  2. VLRS vs DBVT Comparison

VLRS vs DBVT Comparison

Compare VLRS & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Controladora Vuela Compania de Aviacion S.A.B. de C.V.

VLRS

Controladora Vuela Compania de Aviacion S.A.B. de C.V.

HOLD

Current Price

$8.74

Market Cap

923.4M

ML Signal

HOLD

DBVT

DBV Technologies S.A.

BUY

Current Price

$17.15

Market Cap

948.8M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
VLRS
DBVT
Founded
2005
2002
Country
Mexico
France
Employees
7098
90
Industry
Air Freight/Delivery Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
923.4M
948.8M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
VLRS
DBVT
Price
$8.74
$17.15
Analyst Decision
Buy
Buy
Analyst Count
8
7
Target Price
$9.16
$32.04
AVG Volume (30 Days)
524.0K
258.4K
Earning Date
04-27-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.26
EPS
N/A
N/A
Revenue
N/A
$5,636,000.00
Revenue This Year
$13.96
$35.04
Revenue Next Year
$12.62
$2,360.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
35.77
52 Week Low
$4.17
$8.50
52 Week High
$10.80
$26.19

Technical Indicators

Market Signals
Indicator
VLRS
DBVT
Relative Strength Index (RSI) 67.32 43.01
Support Level $8.59 $16.49
Resistance Level $9.81 $17.42
Average True Range (ATR) 0.38 0.94
MACD 0.12 0.06
Stochastic Oscillator 98.13 38.02

Price Performance

Historical Comparison
VLRS
DBVT

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: